The Cockcroft-Gault equation estimates creatinine clearance by combining age, body weight, serum creatinine, and a sex-based correction factor. For serum creatinine measured in mg/dL, the traditional equation is: CrCl = [(140 − age) × weight in kg] ÷ (72 × serum creatinine), with the result multiplied by 0.85 for females. The estimated result is reported in mL/min and is commonly used when medication labeling or a prescribing protocol specifically requires Cockcroft-Gault creatinine clearance.
By Dr. Taimoor Asghar
Published on taimoorasghar.com
What Is Creatinine Clearance?
Creatinine clearance, abbreviated as CrCl, describes the volume of plasma from which creatinine is cleared per unit of time. It is used as an approximation of kidney filtration, although creatinine clearance and glomerular filtration rate are not identical measurements.
Creatinine is produced from normal muscle metabolism. It enters the bloodstream and is removed mainly by the kidneys. Most creatinine is filtered at the glomerulus, but a portion is also secreted by renal tubules. Consequently, measured creatinine clearance can exceed directly measured glomerular filtration rate.
Creatinine clearance can be measured using a timed urine collection or estimated from serum creatinine and patient characteristics. The Cockcroft-Gault equation provides an estimate without requiring a 24-hour urine collection.
What Is the Cockcroft-Gault Equation?
The Cockcroft-Gault equation was published by Donald Cockcroft and Matthew Gault in 1976. It was derived using data from adult men and compared predicted clearance with measured creatinine clearance from urine collections. The authors proposed a 15% reduction for females, which is conventionally applied by multiplying the result by 0.85.
Cockcroft-Gault formula using serum creatinine in mg/dL
For males:
CrCl = [(140 − age in years) × weight in kg] ÷ [72 × serum creatinine in mg/dL]
For females:
CrCl = {[(140 − age in years) × weight in kg] ÷ [72 × serum creatinine in mg/dL]} × 0.85
The result is expressed in mL/min.
Cockcroft-Gault formula using serum creatinine in µmol/L
Serum creatinine reported in micromoles per litre can be converted to mg/dL before using the standard equation:
Serum creatinine in mg/dL = serum creatinine in µmol/L ÷ 88.4
An alternative rearranged formula is sometimes presented for direct use with µmol/L, but converting the laboratory value to mg/dL makes it easier to apply and verify the original equation correctly.
Information Needed to Calculate Creatinine Clearance
You need four core pieces of information:
- Age: Enter the patient’s age in completed years.
- Body weight: Enter the selected weight in kilograms.
- Serum creatinine: Use a recent value obtained while kidney function is reasonably stable.
- Sex-based factor: Multiply the initial result by 0.85 for females under the traditional equation.
Before calculating, confirm the units used for weight and serum creatinine. Entering pounds instead of kilograms or µmol/L instead of mg/dL can produce a dangerously incorrect result.
How to Calculate Creatinine Clearance Step by Step
- Confirm that the patient is an adult. The original Cockcroft-Gault equation was developed for adults and should not be used as a routine pediatric kidney-function equation.
- Check that serum creatinine is reasonably stable. The equation is less reliable when creatinine is changing rapidly, such as during evolving acute kidney injury.
- Convert body weight to kilograms. Divide weight in pounds by 2.2046 when necessary.
- Convert serum creatinine to mg/dL. Divide a result in µmol/L by 88.4.
- Subtract the patient’s age from 140.
- Multiply the result by the selected body weight in kilograms.
- Multiply serum creatinine by 72.
- Divide the numerator by the denominator.
- For a female patient, multiply the result by 0.85.
- Report the answer in mL/min.
Worked Cockcroft-Gault Calculation
Consider a 65-year-old man who weighs 70 kg and has a stable serum creatinine of 1.2 mg/dL.
Step 1: Calculate the numerator
(140 − 65) × 70 = 75 × 70 = 5,250
Step 2: Calculate the denominator
72 × 1.2 = 86.4
Step 3: Divide the numerator by the denominator
5,250 ÷ 86.4 = 60.8 mL/min
The estimated creatinine clearance is approximately 61 mL/min.
For a female patient with the same age, weight, and serum creatinine:
60.8 × 0.85 = 51.7 mL/min
The estimated creatinine clearance would be approximately 52 mL/min.
Which Body Weight Should Be Used?
Body-weight selection is one of the most important and controversial aspects of the Cockcroft-Gault equation. The original equation used body weight, but contemporary patients may differ substantially from the population in which the equation was developed.
Actual body weight
Actual body weight is the patient’s measured weight. It reflects the original equation most directly and may be specified by some medication labels or clinical protocols. However, using actual body weight in a person with obesity can produce a higher estimated clearance because adipose tissue contributes less creatinine production than muscle tissue.
Ideal body weight
Some institutions use ideal body weight when actual weight substantially exceeds expected lean body size. A commonly used adult formula is:
- Male ideal body weight: 50 kg + 2.3 kg for each inch over 5 feet
- Female ideal body weight: 45.5 kg + 2.3 kg for each inch over 5 feet
These formulas are clinical conventions rather than components of the original Cockcroft-Gault equation.
Adjusted body weight
Some protocols use adjusted body weight in patients with obesity:
Adjusted body weight = ideal body weight + 0.4 × (actual body weight − ideal body weight)
No single weight strategy is universally correct for every patient or medication. The appropriate approach depends on the drug’s approved labeling, the evidence used to establish its renal-dose thresholds, the patient’s body composition, and local prescribing policy. A pharmacist or prescribing specialist should review uncertain cases, especially when the result lies close to a dosing cutoff.
How to Interpret a Cockcroft-Gault Result
A lower estimated creatinine clearance generally indicates reduced renal elimination capacity. However, Cockcroft-Gault values should not be interpreted as precise measurements of kidney function or used alone to diagnose chronic kidney disease.
| Estimated CrCl | General interpretation |
|---|---|
| 90 mL/min or higher | Relatively preserved estimated clearance, although kidney disease may still be present if albuminuria or structural abnormalities exist |
| 60–89 mL/min | Mildly reduced estimated clearance |
| 30–59 mL/min | Moderately reduced estimated clearance |
| 15–29 mL/min | Severely reduced estimated clearance |
| Below 15 mL/min | Very severely reduced estimated clearance; urgent clinical review may be required depending on context |
These ranges provide broad clinical context only. They should not be treated as interchangeable with chronic kidney disease GFR categories because Cockcroft-Gault produces an unindexed estimate in mL/min, while laboratory eGFR is usually normalized to a body surface area of 1.73 m².
Creatinine Clearance Versus eGFR
Creatinine clearance and estimated glomerular filtration rate are related but distinct estimates. They should not automatically be substituted for one another.
| Feature | Cockcroft-Gault CrCl | Laboratory eGFR |
|---|---|---|
| Typical output | mL/min | mL/min/1.73 m² |
| Includes body weight | Yes | Not in standard adult CKD-EPI equations |
| Common role | Medication dosing when specifically required | Assessment and staging of chronic kidney disease |
| Modern equation | Developed in 1976 | Often calculated using the 2021 CKD-EPI equation |
| Measures kidney function directly | No | No |
Modern kidney guidelines generally support validated eGFR equations for evaluating chronic kidney disease and for many medication-dosing decisions. Nevertheless, Cockcroft-Gault remains relevant because some drug trials, regulatory labels, and dosing thresholds were developed using estimated creatinine clearance rather than eGFR.
Always follow the kidney-function method specified in the current product information or authoritative prescribing guidance. This is particularly important for medicines with narrow therapeutic ranges or strict renal thresholds.
When Is Cockcroft-Gault Used for Medication Dosing?
The Cockcroft-Gault equation may be required when a medication’s approved labeling defines renal-dose adjustments according to creatinine clearance. Examples can include certain anticoagulants, antimicrobials, cardiovascular medicines, and other renally eliminated drugs, although the required equation varies by product and jurisdiction.
Do not assume that every medication should be dosed using Cockcroft-Gault. Current guidance increasingly accepts validated eGFR equations in many circumstances. The correct method is the one supported by the medication’s labeling, clinical evidence, and relevant local guidance.
When kidney function is near a treatment threshold, consider whether the estimate is reliable. Clinicians may need repeat testing, cystatin C, a combined creatinine-cystatin C equation, measured GFR, measured creatinine clearance, or specialist advice when an inaccurate estimate could cause toxicity or treatment failure.
When the Cockcroft-Gault Equation May Be Unreliable
Acute kidney injury or rapidly changing creatinine
The equation assumes a relatively stable relationship between creatinine production and elimination. During acute kidney injury, serum creatinine may lag behind the true change in filtration, making the estimate misleading.
Very low muscle mass
Frailty, paralysis, limb amputation, prolonged immobility, neuromuscular disease, or severe malnutrition can reduce creatinine production. Serum creatinine may appear reassuringly low even when kidney function is impaired, leading to overestimation of clearance.
Very high muscle mass
People with unusually high muscle mass may have higher serum creatinine despite preserved filtration. This can make creatinine-based equations underestimate kidney function.
Obesity or marked fluid accumulation
The result may vary substantially according to whether actual, ideal, or adjusted body weight is selected. Oedema and ascites can also make measured body weight a poor representation of metabolically active mass.
Pregnancy
Pregnancy changes plasma volume, renal blood flow, filtration, and creatinine handling. The Cockcroft-Gault equation has not been validated as a general dosing tool for all pregnant patients.
Advanced liver disease
Reduced creatinine production, malnutrition, fluid retention, and altered body composition can cause creatinine-based equations to overestimate kidney function in cirrhosis.
Extremes of age
The equation was developed in adults aged 18–92 years but included relatively few people at some extremes. Older adults frequently have reduced muscle mass, which can make apparently normal serum creatinine misleading.
Medications affecting creatinine handling
Some medicines can raise serum creatinine by reducing tubular secretion without producing a corresponding reduction in true glomerular filtration. Interpretation should account for recent medication changes and the clinical context.
Common Cockcroft-Gault Calculation Errors
- Entering serum creatinine in µmol/L without converting it to mg/dL
- Entering weight in pounds rather than kilograms
- Adding age instead of subtracting it from 140
- Applying the 0.85 factor twice
- Using both ideal and adjusted body weight in the same calculation
- Assuming that the highest calculated value is the safest value for drug dosing
- Using an outdated or unrepresentative body weight
- Using the equation during rapidly evolving acute kidney injury without recognizing its limitations
- Treating CrCl in mL/min as identical to eGFR in mL/min/1.73 m²
- Rounding serum creatinine upward without a validated reason
- Changing a medication dose without checking its current product information
Should Low Serum Creatinine Be Rounded Up?
Automatically replacing a low serum creatinine with an arbitrary higher value, such as 1.0 mg/dL, can underestimate kidney function and lead to unnecessary dose reduction. Routine rounding is not part of the original Cockcroft-Gault equation and should not be performed without a specific, evidence-based protocol.
When low serum creatinine is suspected to reflect low muscle mass rather than excellent filtration, the safer response is to recognize the uncertainty and consider additional kidney-function assessment rather than silently changing the laboratory result.
Can Cockcroft-Gault Diagnose Chronic Kidney Disease?
The Cockcroft-Gault equation should not be used alone to diagnose or stage chronic kidney disease. Chronic kidney disease requires evidence of abnormal kidney structure or function persisting for at least three months. Assessment commonly includes laboratory eGFR, urine albumin-to-creatinine ratio, urinalysis, medical history, imaging when indicated, and repeat testing.
A single low creatinine-clearance estimate may reflect acute illness, dehydration, medication effects, measurement variability, or limitations of the equation. It requires interpretation within the wider clinical picture.
When to Seek Clinical or Pharmacy Review
Professional review is especially important when:
- The calculated value is close to a medication-dosing threshold
- Kidney function is changing rapidly
- The patient has severe obesity, low muscle mass, an amputation, ascites, or major oedema
- A medicine has a narrow therapeutic range
- Different kidney-function equations produce conflicting dosing categories
- The serum creatinine result seems inconsistent with the patient’s clinical condition
- The patient is pregnant, critically ill, or receiving dialysis
- Several nephrotoxic or renally eliminated medicines are being used
Key Clinical Message
To calculate creatinine clearance with the Cockcroft-Gault equation, subtract age from 140, multiply by the selected weight in kilograms, divide by 72 times serum creatinine in mg/dL, and multiply by 0.85 for females. The arithmetic is straightforward, but accurate interpretation requires stable creatinine, correct units, appropriate weight selection, and confirmation that Cockcroft-Gault is the kidney-function estimate required for the medication or clinical decision.
Medical disclaimer: This article is for educational purposes and does not provide an individual diagnosis, prescription, or medication-dosing recommendation. Kidney-function estimates can be inaccurate in acute illness, unusual body composition, pregnancy, advanced liver disease, and other special circumstances. Do not start, stop, or change a medication based solely on this article or an online calculator. Consult an appropriately qualified physician or pharmacist for individualized assessment.
Key takeaways
- Cockcroft-Gault estimates creatinine clearance from age, body weight, serum creatinine, and a traditional female correction factor.
- Confirm that weight is entered in kilograms and serum creatinine in mg/dL before performing the calculation.
- Body-weight selection can substantially affect the result, especially in obesity, underweight patients, oedema, or unusual body composition.
- Creatinine clearance in mL/min is not identical to laboratory eGFR in mL/min/1.73 m².
- The equation is less reliable during acute kidney injury, advanced liver disease, pregnancy, or marked abnormalities of muscle mass.
- Use Cockcroft-Gault for medication dosing only when supported by the product information, relevant evidence, or an authoritative clinical protocol.
Frequently asked questions
What is the Cockcroft-Gault equation?
What is the formula for creatinine clearance?
Which weight should be used in the Cockcroft-Gault equation?
Is creatinine clearance the same as eGFR?
Can Cockcroft-Gault be used during acute kidney injury?
Should a low serum creatinine be rounded up to 1 mg/dL?
References
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. https://pubmed.ncbi.nlm.nih.gov/1244564/
- National Institute of Diabetes and Digestive and Kidney Diseases. Determining Drug Dosing in Adults with Chronic Kidney Disease. https://www.niddk.nih.gov/research-funding/research-programs/kidney-clinical-research-epidemiology/laboratory/ckd-drug-dosing-providers
- Kidney Disease: Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024. https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf
- U.S. Food and Drug Administration. Pharmacokinetics in Patients with Impaired Renal Function: Study Design, Data Analysis, and Impact on Dosing. Guidance for Industry. 2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pharmacokinetics-patients-impaired-renal-function-study-design-data-analysis-and-impact-dosing
- Medicines and Healthcare products Regulatory Agency. Prescribing medicines in renal impairment: using the appropriate estimate of renal function to avoid the risk of adverse drug reactions. 2019. https://www.gov.uk/drug-safety-update/prescribing-medicines-in-renal-impairment-using-the-appropriate-estimate-of-renal-function-to-avoid-the-risk-of-adverse-drug-reactions
- National Kidney Foundation. Cockcroft-Gault Equation for Estimating Creatinine Clearance. https://www.kidney.org/professionals/kdoqi/cockcroft-gault-equation-estimating-creatinine-clearance